There are now plenty of companies that are involved in the medical devices industry and one of the more notable players is Therma Bright Inc (TSXV:THRM) (OTCQB:TBRIF). At this point in time, the company is in the news for having developed the AcuVid™ COVID-19 Rapid Antigen Saliva Test, which is smart enabled.
However, it ought to be noted that it has come up with more progressive medical devices which deliver highly innovative and quality solutions. There has not been any news about Therma Bright for some weeks not but it had actually made a major announcement back on August 4 with regards to the AcuVid™ COVID-19 Rapid Antigen Saliva Test.
At the time, the company provided a key update with regards to the test. The company announced that it had continued to be engaged in discussion with the United States Food and Drug Administration with regard to the Emergency Use Authorization for the AcuVid™ COVID-19 Rapid Antigen Saliva Test.
However, that is not all. The company also sought advice from the company Ridge Global as well as other regulatory consultants on the best ways in which it could speed up its application process for the device. It is one of the most important projects for Therma Bright at this point in time and investors could do well to keep an eye on it over the coming days.
The company announced at the time that it had provided its response to the FDA’s request for additional information about the product following the initial review.
Therma Bright also noted that it expected more feedback from the agency once the responses had been submitted. Rob Fia, who is the Chief Executive Officer of the company, thanked the shareholders for their continued support with regard to the current endeavor of the company.